10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 328 filers reported holding 10X GENOMICS INC in Q3 2021. The put-call ratio across all filers is 2.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $32,615,513 | +41.5% | 895,047 | +10.6% | 0.01% | +33.3% |
| Q3 2022 | $23,049,861 | -29.4% | 809,335 | +12.2% | 0.01% | -25.0% |
| Q2 2022 | $32,653,712 | -40.1% | 721,629 | +0.7% | 0.01% | -33.3% |
| Q1 2022 | $54,532,149 | -50.2% | 716,868 | -2.6% | 0.01% | -47.8% |
| Q4 2021 | $109,597,000 | +1.0% | 735,751 | -1.3% | 0.02% | -4.2% |
| Q3 2021 | $108,516,000 | -16.4% | 745,406 | +12.5% | 0.02% | -14.3% |
| Q2 2021 | $129,769,000 | +65.6% | 662,693 | +53.1% | 0.03% | +55.6% |
| Q1 2021 | $78,345,000 | +3041.3% | 432,847 | +2064.2% | 0.02% | +1700.0% |
| Q3 2020 | $2,494,000 | +39.6% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,786,000 | +43.3% | 20,000 | 0.0% | 0.00% | – |
| Q1 2020 | $1,246,000 | -18.3% | 20,000 | 0.0% | 0.00% | – |
| Q4 2019 | $1,525,000 | +51.3% | 20,000 | 0.0% | 0.00% | – |
| Q3 2019 | $1,008,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |